Navigation Links
FluoroPharma Inc. Expands Technology Platform to Include Agents for Alzheimer's Disease (AD)
Date:3/26/2008

BOSTON, March 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced that it has entered into a licensing agreement with Massachusetts General Hospital (MGH) for the development and commercialization of agents for diagnosis and treatment of Alzheimer's disease (AD). The licensed technologies, which were co-developed by FluoroPharma and MGH scientists, target multiple biological processes associated with AD. Currently, there is no single diagnostic test that proves a person has AD. Development of new options for early detection and treatment of Alzheimer's has the potential to improve patient care and create new paths for AD management for the more than 5M Americans that suffer from dementia and other cognitive deficits as a result of AD.

"Our molecular imaging approach to AD includes multiple molecular compositions that target AD associated phenomena -- low acetylcholine and amyloid plaque formation. With some agents, it may be possible to improve brain function by inhibiting the breakdown of acetylcholine, and with others we may be able to prevent the formation of amyloid plaque by inhibiting protein misfolding. As PET imaging tracers, these agents also have potential applications in both diagnosis of the disease and monitoring of the therapy, by differentially accumulating in regions of the brain affected by the disease compared to normal brain tissue," explained Dr. David Elmaleh, FluoroPharma's Chairman and Scientific Founder.

"The technology has the potential to be highly effective due to the agents' enhanced accumulation in the brain," said Dr. Kundakovic, FluoroPharma's President. "As PET imaging agents, these compounds may provide valuable information in patients where early diagnostic and therapeutic information is likely to have the greatest benefit."

About FluoroPharma

FluoroPharma is a molecular imaging company engaged
'/>"/>

SOURCE FluoroPharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
2. Murad Expands International Presence With Appointment of Danny Guez
3. Sigma-Aldrich Amends Credit Facility and Expands Commercial Paper Program
4. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
5. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
6. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
7. Life Spine Expands Home Office Space, More Than Doubling Space Occupied
8. Millennium Expands IBD Franchise with Addition of New Development Candidate
9. inVentiv Clinical Expands Operations to Emerging Latin American Region
10. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
11. AlphaDetail, Inc. Expands Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... (PRWEB) August 22, 2014 Buying a policy ... adult who is unsure about available coverage types by insurers ... principal life insurance policy pricing to the public using its ... of this tool is free and is expected to promote ... to the public throughout the U.S. The system is designed ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 Millennium Treatment ... marijuana, resulting in a high level of drug use among ... ages fight against drug addiction and work to minimize drug ... levels of alcohol and drug addiction in history. According to ... an estimated 23.9 million Americans aged 12 or older—or 9.2 ...
(Date:8/22/2014)... HealthDay Reporter FRIDAY, Aug. 22, ... on work disability chronically use powerful prescription painkillers, according ... 2007 and 2011, about 44 percent of people receiving ... each year. And the percentage using the drugs long-term ... in 2011. Experts said the trend is ...
(Date:8/22/2014)... know little about how Ebola is transmitted and harbor unfounded ... States, a new survey shows. About four in 10 ... major Ebola outbreak in the United States, and one-quarter are ... sick with the deadly virus in the next year, according ... However, those opinions don,t match reality, the Harvard researchers noted. ...
(Date:8/22/2014)... 2014 Natural Clear Vision , a ... his own vision from legally blind to perfect 20/20 vision ... review. , “There is a huge portion of the ... function, and most people just think that’s the way it ... that can be pretty risky at times,” reports Michaels. “This ...
Breaking Medicine News(10 mins):Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2
... RENO, Nev., Nov. 20 Employers Occupational,Health, ... (NYSE: EIG ), announced,today that it ... URAC, a,Washington, D.C.-based health care accrediting organization ... industry. URAC,s Case,Management Accreditation standards require companies ...
... known for years that psychological trauma that results ... change how a person responds to stress. Now, ... loved ones, life-threatening accidents and other such traumas ... survivor doesn,t develop a clinical disorder., "The findings ...
... assumed to be the top truants in American medicine, not ... less treatable. However, a new study by Dartmouth researchers suggests ... through the cracksat least when it comes to colorectal and ... types of cancer, the study found that urban patients tend ...
... Corporation,(Nasdaq: RGEN ) announced today that the Company President ... two upcoming,healthcare conferences in New York, NY. -- Lazard ... Wednesday, November 28, 2007 at 11:00 A.M. EST at ... Madison Avenue, New York, NY. -- BMO Capital Markets ...
... in Molecular Imaging Zone, FORT LAUDERDALE, Fla., ... Board: IMDS) a pioneer in laser,optical breast cancer ... cancer cases imaged with optical computed tomography,technologies at ... - 28. A CT,Laser Mammography (CTLM(R)) system and ...
... 21st, Prey Veng Province, PHNOM PENH, Cambodia, ... AIDS organization in the United,States, which operates free ... and Asia, is honored to announce the opening ... The facility, AHF,s seventh,in the country, opens Wednesday, ...
Cached Medicine News:Health News:Employers Occupational Health, Inc. Receives URAC Case Management Accreditation 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 2Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 2Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 4
(Date:8/22/2014)... Research and Markets  has announced the ... Tools & Technologies" report to their offering. ... products or you wish to expand your product line, ... is. The authors know you want to make effective ... to generate improved revenues and take market share from ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
(Date:8/22/2014)... August 22, 2014 ... Today Lincor announced general availability of ... that delivers a range of education, entertainment and clinical ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " ... of care patient engagement to bedside smart devices, " ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Lincor Unveils Next Generation TV-based Patient Engagement Solution 2
... Biopharmaceuticals Plc, a,biopharmaceutical company focused on the development ... initiated a Phase II,equivalent study of MRX-4, in ... allergic rhinitis (AR). The two-arm, randomized, multi-dose,double-blind, placebo-controlled ... study is expected to be completed by the ...
... Society, American Society of Breast Surgeons and American College ... ... Oncology, SUNNYVALE, Calif., June 24 Xoft, Inc. today announced,the ... national Electronic Brachytherapy patient registry,under oversight from three national physician societies, ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 3First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 4
10 plate suitable for children and the illiterate....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Berke ptosis clamp...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Medicine Products: